JCB Laboratories and Fagron Sterile Services Secure Group Purchasing Organization Contract With Premier Inc.
GPO Awards 503B Human Drug Compounding Outsourcing Contract for Ophthalmics to Fagron Wichita, KS – June 20, 2017 – JCB Laboratories (JCB) and Fagron Sterile Services (FSS), companies of Fagron North America, announced they have...
JCB Laboratories is now providing new information about a plan to expand and relocate its Wichita headquarters. The business, a sterile injectable compounding pharmacy, is…Read More
In the world of sterile compounding, much has changed over the last two years. Prior to the passage of the Drug Quality and Security Act…Read More
The passing of the Drug Quality and Security Act (DQSA) in November of 2013 was one of the most significant events in the compounding industry…Read More
New $15 million drug outsourcing facility largest capital project in Fagron’s history MIAMI – Fagron North America, a leading supplier of compounded medications to hospital…Read More
Dilating patients’ eyes before ophthalmic procedures is quite possibly the most time-consuming part of the eye exam/surgery. Many facilities choose to combine various medications to…Read More
As a high-risk sterile compounder, I routinely run into confusion over the different types of sterile compounding. Not all compounders are the same and understanding…Read More
I received a call recently from a surgery center looking for an intrathecal injection containing morphine, clonidine, and baclofen. Appropriately, the caller was adamant that…Read More
Here is the scenario: for compliance, risk management, and efficiency reasons, you have made the decision to outsource the compounding of combination dilating drops for…Read More
If you are a podiatrist or an ophthalmologist, or you work with either of these specialists, dehydrated alcohol injection is most likely a staple in…Read More